Biocon Biologics
Anita Rao is a highly experienced professional who has worked in various scientific and managerial roles in the biotechnology and pharmaceutical industries. With a strong background in Molecular Biology and Biochemistry, Anita has led projects related to assay development, biosimilar product development, and gene therapy vectors. Currently serving as the Global Head - ASAT at Biocon Biologics, Anita oversees all analytical aspects of biosimilar product development for both developed and emerging markets. Additionally, Anita has a Ph.D in Molecular Biology from the University of Maryland and has pursued executive education in Business Analytics and Intelligence from the Indian Institute of Management Bangalore.
This person is not in the org chart
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics